data-ert-clinical-20.html
Novo Annual Review 2016
21 / 71
e rt is the leading global provider of electronic
data
collection
solutions
for clinical development programmes.
ert
?s cloud-based
solutions
capture quality efficacy and safety endpoints, harmonise
data
from any clinical source system, and deliver real-time insights for optimal trial performance while ensuring patient safety. novo holds 30% of the institutional equity in
ert
plus a portion of the debt. we partnered with nordic capital for this transaction, which was our first investment in a us- headquartered company with global business activities. advancing
data
collection, analysis and reporting
ert
?s combination of technology, services and consulting increases the accuracy and reliability of patient
data
and improves the efficiency of the clinical development process throughout the product lifecycle. the company operates in three main business areas: ? electronic clinical outcomes assessment (ecoa) comprises electronic questionnaires (e.g. probing on degree of pain) to track patient health status. questionnaires are administered by phone or tablet to track and collect patient-reported metrics. digital
solutions
are increasingly used over paper due to low costs, improved
data
quality and subject compliance as well as dynamic functions (e.g. suicide risk al
ert
s). ? cardiac safety involves the collection and interpretation of cardiac
data
using a connected ecg for use in drug safety testing. centralised digital
solutions
are increasingly taking over from paper
data
capture due to the higher
data
quality >50% of fda drug approv- als in past three years were based on
ert
-supported studies ?increased regulations, greater complexity and a highly competitive market are exponentially raising the level of risk for our customers. by investing in advanced technology platforms, providing superior customer service, and identifying problems before they occur, we are helping pharmaceutical and biotech companies bring life-saving therapies to market faster and more cost effectively than ever.? ? jim corrigan, ceo,
ert
fast facts ? established in 1972 ? headquarters: philadelphia ? 1,000 employees in five countries ? jim corrigan, ceo 21 large investments
synlab-laboratory-services-22.html
